Drug
Ciltacabtagene Autoleucel
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Cytokine Release Syndrome | 813 | 159.1 | 184.5 | signal |
| 2 | Parkinsonism | 328 | 124.2 | 131.5 | signal |
| 3 | Neurotoxicity | 192 | 39.9 | 41.2 | signal |
| 4 | Cytopenia | 94 | 28.3 | 28.7 | signal |
| 5 | Full Blood Count Abnormal | 49 | 16.7 | 16.8 | signal |
| 6 | Bacterial Infection | 79 | 15.2 | 15.4 | signal |
| 7 | Myelodysplastic Syndrome | 59 | 14.6 | 14.7 | signal |
| 8 | Transfusion | 32 | 10.9 | 10.9 | signal |
| 9 | Plasma Cell Myeloma | 115 | 10.5 | 10.7 | signal |
| 10 | Colitis | 108 | 10.3 | 10.4 | signal |
| 11 | Adverse Event | 247 | 9.6 | 10.0 | signal |
| 12 | Acute Myeloid Leukaemia | 38 | 8.7 | 8.8 | signal |
| 13 | Laboratory Test Abnormal | 67 | 8.1 | 8.2 | signal |
| 14 | Hospitalisation | 339 | 8.0 | 8.4 | signal |
| 15 | Brain Fog | 32 | 7.8 | 7.9 | signal |
| 16 | Bacteraemia | 23 | 7.0 | 7.0 | signal |
| 17 | Basal Cell Carcinoma | 30 | 6.9 | 6.9 | signal |
| 18 | Viral Infection | 47 | 5.1 | 5.1 | signal |
| 19 | Covid-19 Pneumonia | 16 | 4.8 | 4.8 | signal |
| 20 | Intestinal Perforation | 15 | 4.8 | 4.8 | signal |
| 21 | Paralysis | 19 | 4.7 | 4.7 | signal |
| 22 | Adverse Drug Reaction | 113 | 4.5 | 4.6 | signal |
| 23 | Nervous System Disorder | 38 | 4.3 | 4.4 | signal |
| 24 | Lymphopenia | 17 | 4.3 | 4.3 | signal |
| 25 | Diplopia | 31 | 4.3 | 4.3 | signal |
| 26 | Illness | 117 | 4.2 | 4.2 | signal |
| 27 | Clostridium Difficile Infection | 25 | 4.1 | 4.1 | signal |
| 28 | Haemorrhage Intracranial | 17 | 4.0 | 4.1 | signal |
| 29 | Pyrexia | 380 | 3.9 | 4.1 | signal |
| 30 | Immunodeficiency | 16 | 3.9 | 3.9 | signal |
| 31 | Septic Shock | 43 | 3.6 | 3.6 | signal |
| 32 | Encephalopathy | 24 | 3.5 | 3.5 | signal |
| 33 | Ageusia | 24 | 3.4 | 3.4 | signal |
| 34 | Clostridium Difficile Colitis | 10 | 3.4 | 3.4 | signal |
| 35 | Neutropenia | 126 | 3.3 | 3.4 | signal |
| 36 | Decreased Immune Responsiveness | 9 | 3.3 | 3.3 | signal |
| 37 | Infusion Related Reaction | 60 | 3.2 | 3.3 | signal |
| 38 | Acute Respiratory Distress Syndrome | 16 | 3.2 | 3.2 | signal |
| 39 | Fungal Infection | 30 | 3.2 | 3.2 | signal |
| 40 | Sars-cov-2 Test Positive | 12 | 3.2 | 3.2 | signal |
| 41 | Thrombocytopenia | 99 | 3.2 | 3.2 | signal |
| 42 | Acute Respiratory Failure | 17 | 3.2 | 3.2 | signal |
| 43 | Pancytopenia | 49 | 3.1 | 3.2 | signal |
| 44 | Urosepsis | 8 | 3.1 | 3.1 | signal |
| 45 | Multiple Organ Dysfunction Syndrome | 24 | 3.1 | 3.1 | signal |
| 46 | Infection | 122 | 3.0 | 3.1 | signal |
| 47 | Immune System Disorder | 11 | 3.0 | 3.0 | signal |
| 48 | Platelet Count Decreased | 87 | 2.9 | 2.9 | signal |
| 49 | Sepsis | 89 | 2.8 | 2.9 | signal |
| 50 | Cytomegalovirus Infection | 13 | 2.8 | 2.8 | signal |
| 51 | Dialysis | 11 | 2.8 | 2.8 | signal |
| 52 | Respiratory Failure | 56 | 2.7 | 2.8 | signal |
| 53 | Polyneuropathy | 9 | 2.7 | 2.7 | signal |
| 54 | Product Packaging Issue | 7 | 2.7 | 2.7 | signal |
| 55 | Aspiration | 8 | 2.6 | 2.6 | signal |
| 56 | Febrile Neutropenia | 48 | 2.6 | 2.6 | signal |
| 57 | Malnutrition | 8 | 2.6 | 2.6 | signal |
| 58 | Blood Test Abnormal | 10 | 2.5 | 2.5 | signal |
| 59 | Skin Reaction | 10 | 2.5 | 2.5 | signal |
| 60 | Full Blood Count Decreased | 14 | 2.5 | 2.5 | signal |
| 61 | Malignant Melanoma | 9 | 2.4 | 2.4 | signal |
| 62 | Personality Change | 6 | 2.3 | 2.3 | no signal |
| 63 | Anosmia | 9 | 2.2 | 2.2 | signal |
| 64 | Adverse Reaction | 8 | 2.2 | 2.2 | no signal |
| 65 | Hypersomnia | 17 | 2.1 | 2.1 | signal |
| 66 | Eating Disorder | 12 | 2.0 | 2.0 | signal |
| 67 | Covid-19 | 99 | 2.0 | 2.0 | no signal |
| 68 | Cognitive Disorder | 26 | 2.0 | 2.0 | no signal |
| 69 | Agranulocytosis | 10 | 1.9 | 1.9 | no signal |
| 70 | Mental Status Changes | 15 | 1.9 | 1.9 | no signal |
| 71 | Haematotoxicity | 5 | 1.9 | 1.9 | no signal |
| 72 | Squamous Cell Carcinoma | 5 | 1.9 | 1.9 | no signal |
| 73 | Neoplasm Malignant | 35 | 1.9 | 1.9 | no signal |
| 74 | Blood Lactate Dehydrogenase Increased | 8 | 1.8 | 1.8 | no signal |
| 75 | Motor Dysfunction | 5 | 1.8 | 1.8 | no signal |
| 76 | Gait Inability | 16 | 1.7 | 1.7 | no signal |
| 77 | Disease Progression | 55 | 1.7 | 1.7 | no signal |
| 78 | Mucosal Inflammation | 12 | 1.6 | 1.6 | no signal |
| 79 | Malaise | 195 | 1.6 | 1.6 | no signal |
| 80 | Leukopenia | 21 | 1.5 | 1.5 | no signal |
| 81 | Apathy | 6 | 1.5 | 1.5 | no signal |
| 82 | Hospice Care | 4 | 1.4 | 1.4 | no signal |
| 83 | Movement Disorder | 13 | 1.4 | 1.4 | no signal |
| 84 | Inappropriate Antidiuretic Hormone Secretion | 4 | 1.4 | 1.4 | no signal |
| 85 | Subarachnoid Haemorrhage | 4 | 1.4 | 1.4 | no signal |
| 86 | White Blood Cell Count Decreased | 42 | 1.4 | 1.4 | no signal |
| 87 | Neutrophil Count Decreased | 15 | 1.3 | 1.3 | no signal |
| 88 | Unevaluable Event | 28 | 1.3 | 1.3 | no signal |
| 89 | Upper Limb Fracture | 7 | 1.2 | 1.2 | no signal |
| 90 | Neoplasm | 4 | 1.2 | 1.2 | no signal |
| 91 | Gastrointestinal Carcinoma | 3 | 1.2 | 1.2 | no signal |
| 92 | Posterior Reversible Encephalopathy Syndrome | 3 | 1.1 | 1.1 | no signal |
| 93 | Skin Cancer | 5 | 0.8 | 0.8 | no signal |
| 94 | Lung Neoplasm Malignant | 8 | 0.7 | 0.7 | no signal |
| 95 | Prostate Cancer | 5 | 0.2 | 0.2 | no signal |